Pharmacologic inhibition of beta-adrenergic receptors decreases PD-L1 mediated immunosuppression and improves anti-tumor immune signature in ovarian cancer

被引：0
|
作者：
Thaker, Premal [1 ]
Flint, Melanie [2 ]
Giamas, Georgios [3 ]
Falcinelli, Marta [4 ]
Alhity, Gheed [2 ]
Mampay, Myrthe [5 ]
Allen, Marcus [2 ]
Cilibrasi, Chiara [3 ]
Samuels, Mark [3 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Brighton, Brighton, England
[3] Univ Sussex, Brighton, England
[4] Univ Perugia, Perugia, Italy
[5] Vrije Univ Brussel, Brussels, Belgium
来源：
GYNECOLOGIC ONCOLOGY | 2022年 / 166卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
126
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer
    Meng, Jinyu
    Peng, Jin
    Feng, Jie
    Maurer, Jochen
    Li, Xiao
    Li, Yan
    Yao, Shu
    Chu, Ran
    Pan, Xiyu
    Li, Junting
    Zhang, Ting
    Liu, Lu
    Zhang, Qing
    Yuan, Zeng
    Bu, Hualei
    Song, Kun
    Kong, Beihua
    JOURNAL OF TRANSLATIONAL MEDICINE, 2021, 19 (01)
  • [2] Niraparib exhibits a synergistic anti-tumor effect with PD-L1 blockade by inducing an immune response in ovarian cancer
    Jinyu Meng
    Jin Peng
    Jie Feng
    Jochen Maurer
    Xiao Li
    Yan Li
    Shu Yao
    Ran Chu
    Xiyu Pan
    Junting Li
    Ting Zhang
    Lu Liu
    Qing Zhang
    Zeng Yuan
    Hualei Bu
    Kun Song
    Beihua Kong
    Journal of Translational Medicine, 19
  • [3] Adipocyte PD-L1 suppresses anti-tumor immune response and promotes breast cancer progression
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Chiang, Huai-Chin
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    JOURNAL OF IMMUNOLOGY, 2020, 204 (01):
  • [4] Alterations in PD-L1 succinylation shape anti-tumor immune responses in melanoma
    Liang, Long
    Kuang, Xinwei
    He, Yi
    Zhu, Lin
    Lau, Poyee
    Li, Xin
    Luo, Dingan
    Gong, Lan
    Zhou, Wenbin
    Zhang, Fanglin
    Liang, Xiaowei
    Li, Zhuofeng
    Hu, Bin
    Liu, Dandan
    Ding, Tao
    Li, Hui
    Zhao, Shuang
    Su, Juan
    Hung, Mien-Chie
    Liu, Jing
    Liu, Hong
    Chen, Xiang
    NATURE GENETICS, 2025, 57 (03) : 680 - 693
  • [5] Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer
    Falcinelli, M.
    Al-Hity, G.
    Baron, S.
    Mampay, M.
    Allen, M. C.
    Samuels, M.
    Jones, W.
    Cilibrasi, C.
    Flaherty, Renee L.
    Giamas, G.
    Thaker, P. H.
    Flint, M. S.
    BRAIN BEHAVIOR AND IMMUNITY, 2023, 110 : 1 - 12
  • [6] Rhamnazin Enhanced Anti-Tumor Efficacy of Anti-PD-1 Therapy for Lung Cancer in Mice through Inhibition of PD-L1 Expression
    Wang, Shu Shi
    Liu, Ye
    Zhang, Xuan Ting
    Yu, Dong Qiang
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2023, 260 (01): : 63 - 73
  • [7] BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
    Zhu, Hengrui
    Bengsch, Fee
    Svoronos, Nikolaos
    Rutkowski, Melanie R.
    Bitler, Benjamin G.
    Allegrezza, Michael J.
    Yokoyama, Yuhki
    Kossenkov, Andrew V.
    Bradner, James E.
    Conejo-Garcia, Jose R.
    Zhang, Rugang
    CELL REPORTS, 2016, 16 (11): : 2829 - 2837
  • [8] Addition of metformin to anti-PD-1/PD-L1 drugs activates anti-tumor immune response in peripheral immune cells of NSCLC patients
    Luisa Amato
    Caterina De Rosa
    Gaetano Di Guida
    Filippo Sepe
    Annalisa Ariano
    Sara Capaldo
    Faiz Ul Haq
    Alessandra Di Liello
    Concetta Tuccillo
    Stefano Lucà
    Renato Franco
    Viviana De Rosa
    Francesca Iommelli
    Alberto Servetto
    Fortunato Ciardiello
    Carminia Maria Della Corte
    Floriana Morgillo
    Cell Death & Disease, 16 (1)
  • [9] Honokiol suppress the PD-L1 expression to improve anti-tumor immunity in lung cancer
    Luo, Lianxiang
    Wu, Tong
    Ji, Miaorong
    Xiang, Jing
    Zou, Youwen
    Liao, Yinglin
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 133
  • [10] IGF1R inhibition and PD-1 blockade improve anti-tumor immune response in epithelial ovarian cancer
    Somri-Gannam, Lina
    Meisel-Sharon, Shilhav
    Hantisteanu, Shay
    Bar-Noy, Tomer
    Sigal, Emiliya
    Groisman, Gabriel
    Hallak, Mordechai
    Werner, Haim
    Bruchim, Ilan
    FRONTIERS IN ONCOLOGY, 2024, 14
12345